Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 2Phase 4 1Phase 3 1

Status

Completed 47Recruiting 31Active not recruiting 27Terminated 17Unknown 11Not yet recruiting 4Withdrawn 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Genitourinary 1

Conditions

Carcinoma, Hepatocellular 2Lung Neoplasms 1Kidney Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 75Cisplatin 73Bevacizumab 64Radiotherapy 57Drug Therapy 56Capecitabine 56tislelizumab 54Oxaliplatin 54Gemcitabine 46toripalimab 45Paclitaxel 45Specimen Handling 43sintilimab 39pembrolizumab 39anlotinib 38Cyclophosphamide 33130-nm albumin-bound paclitaxel 32Magnetic Resonance Spectroscopy 27Injections 27camrelizumab 26Pemetrexed 26Surgical Procedures, Operative 25lenvatinib 23Docetaxel 23Biopsy 23apatinib 22Etoposide 22Immune Checkpoint Inhibitors 21S 1 (combination) 20Fluorouracil 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Not yet recruiting × cabozantinib × Clear all
NCT07151326 2025-09-03

CAPIO

National Health Research Institutes, Taiwan

Phase 2 Not yet recruiting
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06535737 2024-08-02

CPAB

Chulalongkorn University

Phase 2 Not yet recruiting
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05859217 2024-05-08

Cabatezo-1

University of Kansas Medical Center

Phase 2 Not yet recruiting
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05241561 2022-06-01

Cabo-POLARIS

Centre Hospitalier Universitaire de Besancon

Phase 2 Not yet recruiting
24 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡